Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Italian with Elisa (PDF)
Volume 1 | Volume 2

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 150 articles:
HTML format
Text format



Single Articles


    March 2015
  1. RODRIGUES-PINTO E, Cardoso H, Coelho R, Andrade P, et al
    Higher aspartate aminotransferase platelet ratio index predicts early significant liver-related events in hepatitis C genotype 1 chronic liver disease.
    Eur J Gastroenterol Hepatol. 2015;27:361-2.
    PubMed     Text format    


    February 2015
  2. TAPAN S
    Assessment of the neutrophil to lymphocyte ratio in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2015;27:184-5.
    PubMed     Text format    


    January 2015
  3. YAN S, Wu H, Wang G, Chen Y, et al
    A new model combining the liver/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  4. FLISIAK R, Halota W, Tomasiewicz K, Kostrzewska K, et al
    Forecasting the disease burden of chronic hepatitis C virus in Poland.
    Eur J Gastroenterol Hepatol. 2015;27:70-6.
    PubMed     Text format     Abstract available


    December 2014
  5. BESTE LA, Green PK, Ioannou GN
    Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  6. NAKAGAWA A, Atsukawa M, Tsubota A, Shimada N, et al
    Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.
    Eur J Gastroenterol Hepatol. 2014;26:1329-34.
    PubMed     Text format     Abstract available


    November 2014
  7. MAO W, Hu Y, Lou Y, Chen Y, et al
    Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  8. LI D, Gao G, Jiang H, Tang Z, et al
    Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    October 2014
  9. BUTI M, Morillas RM, Perez J, Prieto M, et al
    Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  10. KOLLER T, Kollerova J, Huorka M, Meciarova I, et al
    Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2014;26:1108-15.
    PubMed     Text format     Abstract available


    September 2014
  11. YLMAZ B, Aydn H, Can G, Senturk Z, et al
    The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  12. KARAGOZ E, Ulcay A, Tanoglu A, Kara M, et al
    Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  13. UYANIK M, Sertoglu E, Kayadibi H
    Early diagnosis of autoimmune hepatitis on the basis of demographic and biochemical parameters.
    Eur J Gastroenterol Hepatol. 2014;26:1060-1.
    PubMed     Text format    


  14. REMY AJ, Lesgourgues B, Nalet B, Causse X, et al
    Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C: is early prediction possible?
    Eur J Gastroenterol Hepatol. 2014;26:996-1002.
    PubMed     Text format     Abstract available


    August 2014
  15. YEE BE, Nguyen NH, Zhang B, Vutien P, et al
    Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  16. LV N, Chu XD, Sun YH, Zhao SY, et al
    Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  17. STAHMEYER JT, Rossol S, Bert F, Antoni C, et al
    Cost of treating hepatitis C in Germany: a retrospective multicenter analysis.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  18. VAN GERVEN NM, Bakker SF, de Boer YS, Witte BI, et al
    Seroprevalence of celiac disease in patients with autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  19. ABBAS Z, Soomro GB, Hassan SM, Luck NH, et al
    Clinical presentation of hepatitis D in Pakistani children.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  20. MAASOUMY B, Port K, Deterding K, Honer Zu Siederdissen C, et al
    Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.
    Eur J Gastroenterol Hepatol. 2014;26:836-45.
    PubMed     Text format     Abstract available


    July 2014
  21. HEIDRICH B, Cetindere A, Beyaz M, Stahmeyer JT, et al
    High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  22. JUAN JD, de la Hoya PS, Marco A, Anton JJ, et al
    Multicenter study on the discontinuation and efficacy of chronic hepatitis C treatment in the Spanish penitentiary population (EPIBAND study).
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  23. TURKER K, Albayrak M, Oksuzoglu B, Balc E, et al
    Entecavir as a first-line treatment for hepatitis B virus reactivation following polychemotherapy for chronic lymphocytic leukemia and invasive ductal carcinoma: a report of two cases and review of the literature.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  24. ASSAL A, Mackie D, Cooper CL
    Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  25. BAKER D, Alavi M, Erratt A, Hill S, et al
    Delivery of treatment for hepatitis C virus infection in the primary care setting.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  26. LAUFFENBURGER JC, Mayer CL, Hawke RL, Brouwer KL, et al
    Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  27. ZHANG ZY, Zhou ZQ, Zhou GW
    Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  28. OZARAS R, Mete B, Ceylan B, Ozgunes N, et al
    First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment.
    Eur J Gastroenterol Hepatol. 2014;26:774-80.
    PubMed     Text format     Abstract available


  29. DI BISCEGLIE AM, Sulkowski M, Gane E, Jacobson IM, et al
    VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2014;26:761-73.
    PubMed     Text format     Abstract available


    June 2014
  30. VEIGA Z, Pereira GH, Fernandes FF, Mariz DM, et al
    Reply to: Telaprevir-induced acute kidney injury during treatment of chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2014;26:687-8.
    PubMed     Text format    


    April 2014
  31. SHAHID M, Idrees M, Nasir B, Raja AJ, et al
    Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  32. ATSUKAWA M, Tsubota A, Shimada N, Kondo C, et al
    Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  33. CEYLAN B, Aslan F, Yardimci C, Fincanci M, et al
    Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries.
    Eur J Gastroenterol Hepatol. 2014;26:493-4.
    PubMed     Text format    


  34. PANAYI V, Froud OJ, Vine L, Laurent P, et al
    The natural history of autoimmune hepatitis presenting with jaundice.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  35. WANG WL, Zhu Y, Cheng JW, Li MX, et al
    Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.
    Eur J Gastroenterol Hepatol. 2014;26:444-51.
    PubMed     Text format     Abstract available


    March 2014
  36. AZIZ H, Gill U, Raza A, Gill ML, et al
    Metabolic syndrome is associated with poor treatment response to antiviral therapy in chronic hepatitis C genotype 3 patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  37. JERKEMAN A, Norkrans G, Lidman C, Westin J, et al
    Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  38. EFE C, Ozaslan E, Heurgue-Berlot A, Kav T, et al
    Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  39. ZHANG Q, Shang L, Zang Y, Chen X, et al
    alpha-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    February 2014
  40. YANG X, Li J, Zhou L, Liu J, et al
    Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  41. CRAXI A, Piccinino F, Ciancio A, Iannacone C, et al
    Real-world outcomes in patients with chronic hepatitis C: primary results of the PROBE study.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  42. CHU KJ, Lu CD, Dong H, Fu XH, et al
    Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Eur J Gastroenterol Hepatol. 2014;26:192-9.
    PubMed     Text format     Abstract available


  43. GUNER R, Kocak Tufan Z
    Telaprevir use in a chronic hepatitis C patient with hemophilia.
    Eur J Gastroenterol Hepatol. 2014;26:248.
    PubMed     Text format    


  44. MESSORI A, Fadda V, Maratea D, Trippoli S, et al
    Pegylated interferon-alpha2a versus pegylated interferon-alpha2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis.
    Eur J Gastroenterol Hepatol. 2014;26:246-8.
    PubMed     Text format    


  45. CRISPO A, Barba M, Malvezzi M, Ciliberto G, et al
    Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data.
    Eur J Gastroenterol Hepatol. 2014;26:245-6.
    PubMed     Text format    


  46. KIKUCHI H, Numao H
    Telaprevir-induced acute kidney injury during treatment of chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2014;26:244-5.
    PubMed     Text format    


  47. AOUFI RABIH S, Alfaya Munoz LB, Fidalgo Broncano A, Villanueva Hernandez R, et al
    Should we investigate retinopathy in chronic hepatitis C patients receiving treatment with interferon?
    Eur J Gastroenterol Hepatol. 2014;26:242-3.
    PubMed     Text format    


  48. CEYLAN B, Fincanci M, Yardimci C, Eren G, et al
    Mean platelet volume in chronic viral hepatitis.
    Eur J Gastroenterol Hepatol. 2014;26:240-1.
    PubMed     Text format    


  49. ERGUL B, Sarikaya M, Dogan Z, Filik L, et al
    Is liver biopsy a problem for patients on chronic hemodialysis?
    Eur J Gastroenterol Hepatol. 2014;26:241-2.
    PubMed     Text format    


    January 2014
  50. RAMSOEKH D, Taimr P, Vanwolleghem T
    Reversible severe hepatitis in anorexia nervosa: a case report and overview.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    December 2013
  51. FUJIWARA K , Yasui S, Yokosuka O
    Corticosteroid for severe acute exacerbation of chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013;25:1492.
    PubMed     Text format    


    October 2013
  52. BUTT FA , Amin I, Idrees M, Iqbal M, et al
    Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  53. ABD ELRAZEK AE , Mahfouz HM, Metwally AM, El-Shamy AM, et al
    Mortality prediction of nonalcoholic patients presenting with upper gastrointestinal bleeding using data mining.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


    September 2013
  54. KOFFI J , Egounlety R, Pradat P, Lebosse F, et al
    Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


    August 2013
  55. SAITO M , Seo Y, Yano Y, Momose K, et al
    Serum albumin and prothrombin time before entecavir treatment in chronic hepatitis B or cirrhosis are related to amelioration of liver function after treatment.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  56. AALOUANE R, Hafidi H, Rammouz I
    Bipolar disorder and interferon treatment: how to manage?
    Eur J Gastroenterol Hepatol. 2013;25:1002.
    PubMed     Text format    


    July 2013
  57. SAGRINI E , Ardoino I, Marano G, Gianstefani A, et al
    Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


    June 2013
  58. NORTH CS , Devereaux R, Pollio DE, Hong BA, et al
    Patient perspectives on hepatitis C and its treatment.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  59. NIEDERAU C , Mauss S, Boker K, Lutz T, et al
    Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  60. WAQAR M , Khan AU, Rehman HU, Idrees M, et al
    Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan).
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  61. FABRIS P , Carlotto A, Bianco TD, Malfatti F, et al
    Therapy of chronic hepatitis C with PEG-IFN alpha-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analyses.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  62. POTTS JR , Howard MR, Verma S
    Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes.
    Eur J Gastroenterol Hepatol. 2013;25:659-64.
    PubMed     Text format     Abstract available


    May 2013
  63. GIORDANINO C , Sacco M, Ceretto S, Smedile A, et al
    Durability of the response to peginterferon-alpha2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  64. VIGANI AG , Tozzo R, Quezada A, Diaz AC, et al
    Chronic hepatitis C virus infection: it is not only about the liver.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  65. DOGAN UB , Akin MS, Yalaki S
    Sustained virological response based on the week 4 response in hepatitis C virus genotype 1 patients treated with peginterferons alpha-2a and alpha-2b, plus ribavirin.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  66. SOCKALINGAM S , Blank D, Banga CA, Mason K, et al
    A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  67. KELLY EM , Cooper CL
    Hepatitis C antiviral treatment outcomes are comparable between clinical trial participants and recipients of standard-of-care therapy: an analysis of trial effect.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  68. DONAGHY L , Barry FJ, Hunter JG, Stableforth W, et al
    Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  69. DOGAN UB , Golge N, Akin MS
    The comparison of the efficacy of pegylated interferon alpha-2a and alpha-2b in chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  70. BALTA S , Demirkol S, Akgul EO
    Mean platelet volume as a surrogate marker of inflammation in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format    


    April 2013
  71. EFE C , Heurgue-Berlot A, Ozaslan E, Purnak T, et al
    Late autoimmune hepatitis after hepatitis C therapy.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  72. ULLAH S , Rehman HU, Idrees M
    Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  73. LIU J , Yu W, Liu S
    Positive ratio of specific antibodies to F protein in serum samples from chronic HCV-infected patients using an enzyme-linked immunosorbent assay: systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  74. SUK KT , Kim HC, Namkung S, Han SH, et al
    Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  75. BRUNNER N , Senn O, Rosemann T, Falcato L, et al
    Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  76. HUANG Z , Deng H, Zhao Q, Zheng Y, et al
    Peginterferon-alpha2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  77. EL RAY A , Asselah T, Moucari R, El Ghannam M, et al
    Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2013;25:421-7.
    PubMed     Text format     Abstract available


  78. ZENI LP , Viera PD, Michalczuk MT, Birkhan OA, et al
    Hepatitis C virus induces abnormalities in surface and intraocular pressure: a comparative study.
    Eur J Gastroenterol Hepatol. 2013;25:411-5.
    PubMed     Text format     Abstract available


  79. AL-ASHGAR HI , Khan MQ, Helmy A, Al-Thawadi S, et al
    Relationship of interferon-gamma-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.
    Eur J Gastroenterol Hepatol. 2013;25:404-10.
    PubMed     Text format     Abstract available


    March 2013
  80. HE B , Zhang Y, Lu MH, Cao YL, et al
    Glucocorticoids can increase the survival rate of patients with severe viral hepatitis B: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  81. DOGAN UB , Atabay A, Akin MS, Yalaki S, et al
    The comparison of the efficacy of pegylated interferon alpha-2a and alpha-2b in chronic hepatitis C patients with genotype 1.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  82. HYDES T , Allen H, Al-Shamma S, Hovell C, et al
    District general hospital networks can provide safe and effective hepatitis C treatment: results of a 5-year audit.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  83. UCAR F , Sezer S, Ginis Z, Ozturk G, et al
    APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  84. CHEN L , Liu W, Lai S, Li Y, et al
    Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  85. KUMARI N , Kathuria R, Srivastav A, Krishnani N, et al
    Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children.
    Eur J Gastroenterol Hepatol. 2013;25:333-7.
    PubMed     Text format     Abstract available


    February 2013
  86. ANSARI MA , Irshad M, Agarwal SK, Chosdol K, et al
    Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  87. SAAD Y , Ahmed A, Saleh DA, Doss W, et al
    Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  88. PAPADOPOULOS N , Manolakopoulos S, Deutsch M, Mela M, et al
    Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  89. MA Q , Qin B, Gong X, Lu X, et al
    Prediction of response to interferon alpha-1b in HBeAg-positive chronic hepatitis B: a clue from HBsAg levels.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  90. ZHANG Y , Lian JQ, Li Y, Wang JP, et al
    Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  91. PAPASTERGIOU V , Stampori M, Lisgos P, Pselas C, et al
    Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective stud
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


    January 2013
  92. MA J , Jiang Y, Gong G
    Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  93. CEYLAN B , Fincanci M, Yardimci C, Eren G, et al
    Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  94. DE VROEY B , Moreno C, Laleman W, van Gossum M, et al
    Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  95. LEE HK , Kim KA, Lee JS, Kim NH, et al
    Window period of anti-hepatitis A virus immunoglobulin M antibodies in diagnosing acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  96. KNOP V , Bergk A, Schlosser B, Thieringer J, et al
    Bezafibrate maintenance therapy in patients with advanced chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


  97. AKSOY EK , Yilmaz B, Koklu S
    Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome developed in a patient with vitiligo and Hashimoto thyroiditis.
    Eur J Gastroenterol Hepatol. 2013;25:121-2.
    PubMed     Text format    


    December 2012
  98. MA P , Yang JM, Hou W, Song SD, et al
    A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  99. KANT J , Moller B, Heyne R, Herber A, et al
    Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  100. AKSU HS , Kurtaran B, Onlen Y, Namiduru M, et al
    Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
    Eur J Gastroenterol Hepatol. 2012;24:1393-1399.
    PubMed     Text format     Abstract available


    November 2012
  101. LIU A , Ha NB, Lin B, Yip B, et al
    Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    October 2012
  102. CARDOSO C , Alves AL, Augusto F, Freire R, et al
    Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  103. GULNAZ A , Sayyed AH, Amin F, Khan AU, et al
    Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  104. NAYAK NC , Jain D, Vasdev N, Gulwani H, et al
    Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants.
    Eur J Gastroenterol Hepatol. 2012;24:1199-208.
    PubMed     Text format     Abstract available


    September 2012
  105. SOYKAN I , Yakut M, Keskin O
    Hepatitis C virus antibody positivity may not be associated with hepatitis C infection in patients with autoimmune gastritis.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format    


  106. EL-MEZAYEN HA , Toson ES, Shiha GE
    Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  107. LILEA GC , Streba CT, Vere CC, Rogoveanu I, et al
    Treatment with Peg-IFNalpha2a/ribavirin and low-dose NSAID for patients with chronic hepatitis C and rheumatoid syndrome.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  108. GHEORGHE L , Csiki IE, Iacob S, Gheorghe C, et al
    The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  109. SIMSEK H , Alp A, Yilmaz B, Balaban YH, et al
    The genotype frequencies of IL28B polymorphisms (rs12979860, rs8099917) among Turkish patients with hepatitis C.
    Eur J Gastroenterol Hepatol. 2012;24:1113-5.
    PubMed     Text format    


    August 2012
  110. MUSIALIK J , Suchecka W, Klimacka-Nawrot E, Petelenz M, et al
    Taste and appetite disorders of chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  111. GUO Y , Zhang W, Zhang Y, Lin X, et al
    Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  112. VOICAN CS , Naveau S, Perlemuter G
    Successful antiviral therapy for hepatitis C virus-induced cirrhosis after an increase in the platelet count with romiplostim: two case reports.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  113. HARTLEB M , Gutkowski K, Zejda JE, Chudek J, et al
    Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey - PolSenior.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    July 2012
  114. NEVENS F , Colle I, Michielsen P, Robaeys G, et al
    Resource use and cost of hepatitis C-related care.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  115. KARABAY O , Tuna N, Esen S
    Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  116. DABROWSKA MM , Mikula T, Wiercinska-Drapalo A
    HCV coinfection possibly promotes left ventricular dysfunction development: analysis of brain natriuretic peptide serum levels in HCV/HIV-coinfected and HIV-monoinfected patients.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  117. GRADY BP , Vanhommerig JW, Schinkel J, Weegink CJ, et al
    Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  118. CHATZIDAKI V , Choumerianou D, Dimitriou H, Kouroumalis E, et al
    Genetic variants associated with susceptibility to mother-to-child transmission of hepatitis B virus.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    June 2012
  119. SINGAL AK , Kuo YF, Anand BS
    Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  120. RIJCKBORST V , Ferenci P, Akdogan M, Pinarbasi B, et al
    Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    May 2012
  121. CHIN JL , Nicholas RM, Russell J, Carr M, et al
    Spontaneous clearance of hepatitis C infection after liver transplantation from IL28B rs12979860 CC donors.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  122. DACOSTA DIBONAVENTURA M , Yuan Y, Wagner JS, L'italien GJ, et al
    The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  123. KARATAPANIS S , Skorda L, Marinopoulos S, Papastergiou V, et al
    Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  124. ESKESEN AN , Melum E, Moghaddam A, Bjoro K, et al
    Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  125. NING LH , Hao J, Liao ZL, Zhou YY, et al
    A survey on the current trends in the management of hepatitis B in China.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  126. KARCHAVA M , Sharvadze L, Chkhartishvili N, Nelson K, et al
    IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  127. EFE C , Wahlin S, Ozaslan E, Berlot AH, et al
    Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.
    Eur J Gastroenterol Hepatol. 2012;24:531-4.
    PubMed     Text format     Abstract available


  128. ZENG QA , Qiu J, Hong J, Li Y, et al
    Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis.
    Eur J Gastroenterol Hepatol. 2012;24:575-82.
    PubMed     Text format     Abstract available


    April 2012
  129. DELLA CORTE C , Sartorelli MR, Sindoni CD, Girolami E, et al
    Autoimmune hepatitis in children: an overview of the disease focusing on current therapies.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  130. KELLY EM , Corace K, Emery J, Cooper CL, et al
    Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  131. ABBAS E , Shaker O, Abd El Aziz G, Ramadan H, et al
    Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Eur J Gastroenterol Hepatol. 2012;24:458-63.
    PubMed     Text format     Abstract available


    March 2012
  132. INNES HA , Hutchinson SJ, Allen S, Bhattacharyya D, et al
    Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    February 2012
  133. BUTI M , Morillas RM, Prietoj M, Diago M, et al
    Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  134. TANWAR S , Wright M, Foster GR, Ryder SD, et al
    Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon alpha-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  135. MOHAMED AF , Johnson FR, Hauber AB, Lescrauwaet B, et al
    Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    January 2012
  136. FLOREANI A , Antoniazzi S, Mescoli C, Bergasa NV, et al
    Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  137. WU DL , Xu GH, Lu SM, Ma BL, et al
    Age versus clinical virological characteristics in chronic hepatitis B virus infection: a case series study in China.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  138. ARAI M , Togo S, Kanda T, Fujiwara K, et al
    Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


  139. WELTE S , Gagesch M, Weber A, Longerich T, et al
    Fulminant liver failure in Wilson's disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both?
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Abstract available


    December 2011
  140. GOSWAMI RP , Goswami RP, Ray Y, Rahman M, et al
    Absolute CD4 counts in monoinfected chronic hepatitis B patients in the advanced immune-active stage.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format    


    November 2011
  141. LIN YM , Sheu MJ, Kuo HT, Feng IC, et al
    The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy.
    Eur J Gastroenterol Hepatol. 2011;23:990-6.
    PubMed     Text format     Abstract available


  142. BUGDACI MS , Sokmen M, Toptas T
    Additive effect of folic acid deficiency on pegylated interferon's bone marrow toxicity.
    Eur J Gastroenterol Hepatol. 2011;23:1079-80.
    PubMed     Text format    


  143. HUISMAN EJ , Trip EJ, Siersema PD, van Hoek B, et al
    Protein energy malnutrition predicts complications in liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2011;23:982-9.
    PubMed     Text format     Abstract available


  144. BOURSIER J , Chaigneau J, Roullier V, Laine F, et al
    Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
    Eur J Gastroenterol Hepatol. 2011;23:974-81.
    PubMed     Text format     Abstract available


    October 2011
  145. SARTORI M , Andorno S, Rossini A, Boldorini R, et al
    A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Abstract available


  146. FLISIAK R , Halota W, Horban A, Juszczyk J, et al
    Prevalence and risk factors of HCV infection in Poland.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Abstract available


  147. YU JW , Sun LJ, Zhao YH, Kang P, et al
    The study of relationship between neutropenia and infection during treatment with peginterferon alpha and ribavirin for chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Abstract available


  148. AMER ME , El-Sayed SZ, El-Kheir WA, Gabr H, et al
    Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
    Eur J Gastroenterol Hepatol. 2011;23:936-41.
    PubMed     Text format     Abstract available


    September 2011
  149. TAFAREL JR , Tolentino LH, Correa LM, Bonilha DR, et al
    Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers.
    Eur J Gastroenterol Hepatol. 2011;23:754-8.
    PubMed     Text format     Abstract available


    July 2011
  150. KUMAR M , Kamani L, Hussain R, Siddique S, et al
    Successful pregnancy outcome in decompensated chronic liver disease with portal vein thrombosis: case report and review of literature.
    Eur J Gastroenterol Hepatol. 2011;23:617-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: